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SUMMARY
Recent research reveals that dysfunction and subse-
quent loss of mitochondria (mitophagy) is a potent
inducer of skeletal muscle wasting. However, the
molecular mechanisms that govern the deregulation
of mitochondrial function during muscle wasting are
unclear. In this report, we show that differentmuscle-
wasting stimuli upregulatedmitochondrial E3 ubiqui-
tin protein ligase 1 (Mul1), through a mechanism
involving FoxO1/3 transcription factors. Overexpres-
sion of Mul1 in skeletal muscles and myoblast
cultures was sufficient for the induction of mitoph-
agy. Consistently, Mul1 suppression not only pro-
tected against mitophagy but also partially rescued
the muscle wasting observed in response to
muscle-wasting stimuli. In addition, upregulation of
Mul1, while increasingmitochondrial fission, resulted
in ubiquitination and degradation of the mitochon-
drial fusion protein Mfn2. Collectively, these data
explain the molecular basis for the loss of mitochon-
drial number during muscle wasting.
INTRODUCTION
Skeletal muscle loss can arise either from primary myopathies,
namelymuscular dystrophy, or as a secondary symptom associ-
ated with cancer, AIDS, sepsis, obesity, aging, and diabetes
(Dodson et al., 2011; Emery, 2002; Evans, 2010; Lecker, 2003).
Earlier studies conducted on wasting skeletal muscles have
identified that overstimulation of the ubiquitin-proteasome path-
way promotes the loss of myofibrillar proteins (Bodine et al.,
2001; Clarke et al., 2007; Cohen et al., 2009; Lokireddy et al.,
2011a, 2011b). Unlike the ubiquitin-proteasome pathway, the
role of the autophagy-lysosome pathway in skeletal muscle is
less understood. However, reports have confirmed that the auto-
phagy-lysosome pathway is critical for maintaining physiological
skeletal muscle mass, as deletions in important autophagy-
related proteins result in skeletal muscle dysfunction (Masiero
et al., 2009). Importantly, inhibition of autophagy also promotes
the accumulation of nuclear abnormalities, reduces cell viability,
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2009; Park et al., 2009). Furthermore, impaired lysosome-
dependent degradation causes myopathies like Pompe and
Danon diseases (Temiz et al., 2009). Conversely, elevated auto-
phagy-lysosome pathway activity also results in myofibrillar and
mitochondrial protein degradation (Bechet et al., 2005).
FoxO transcription factors, downstream targets of the IGF-1/
Akt pathway, stimulate the ubiquitin-proteasome system in
response to skeletal muscle-wasting stimuli, including starva-
tion, denervation, and exposure to glucocorticoids such as
Dexamethasone (Bodine et al., 2001; Sandri et al., 2004). Recent
work has also demonstrated thatMyostatin, a TGF-b superfamily
member involved in the negative regulation of skeletal muscle
growth and development, activated FoxO transcription factors
in murine and human myotubes, which in turn enhanced ubiqui-
tin-proteasome system activity and promoted muscle wasting
(Kambadur et al., 1997; Lee and McPherron, 2001; Lokireddy
et al., 2011a, 2011b; McFarlane et al., 2006; Zhou et al., 2010).
FoxO3 has also been shown to induce the transcription
of numerous genes involved with the autophagy-lysosome
pathway, such as LC3, Atg7, Bnip3, Cathepsin L, and Gabarap1,
in response to starvation and denervation, further implicating
FoxO transcription factors as master regulators of the skeletal
muscle-wasting program (Mammucari et al., 2007; Romanello
et al., 2010; Zhao et al., 2007).
Enhanced activity of FoxO transcription factors has also
been associated with disruption of mitochondrial function and
organization (Romanello et al., 2010). Furthermore,mitochondrial
dysfunction leads to impaired skeletal muscle function and
development (Chen et al., 2010; Romanello et al., 2010). Pertur-
bations in the structure, number, and function of mitochondria
have also been linked to neuropathy and several metabolic
diseases (Chen et al., 2007, 2010; Romanello et al., 2010; Youle
andNarendra, 2011). For example,mitochondrial fusionproteins,
namely mitofusin 2 (Mfn2), which is critical for maintenance and
genomic stability of mitochondrial DNA (mtDNA) (Chen et al.,
2010), were repressed in skeletal muscles isolated from both
obese and nonobese diabetic patients (Bach et al., 2003; Lin
et al., 2005; Soriano et al., 2006). Additionally, mutations in Par-
kin, an E3 ligase, andPink1, amitochondrial kinase that regulates
Parkin function, are associatedwith impaired clearance of defec-
tive mitochondria, which in turn results in the onset of recessive
Parkinson’s disease (Gegg et al., 2010; Geisler et al., 2010).
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Mul1-Induced Mitophagy during Muscle WastingAlthough significant efforts have unveiled numerousmolecular
candidates that regulate mitochondria function during metabolic
and neuropathic disorders, the molecules that modulate mito-
chondrial number and activity during skeletal muscle wasting
are not well known. In this report, we show that themitochondrial
ubiquitin ligase, Mul1 (mitochondrial E3 ubiquitin protein
ligase 1), promotes the fragmentation, depolarization, and
clearance of mitochondria through the autophagy-lysosome
pathway during in vitro and in vivo skeletal muscle wasting. We
further show that Mul1 overexpression during skeletal muscle
wasting was mediated by FoxO3 and that the RING finger
domain of Mul1 ubiquitinated and targeted Mfn2 for ubiquitin-
proteasome-mediated degradation.
RESULTS
Dexamethasone, Myostatin, and Serum Starvation
Perturbed Mitochondrial Architecture and Membrane
Potential, and Promoted Mitochondrial DNA Depletion
in C2C12 Cells
To assessmitochondrial organization duringmuscle wasting, we
transfected C2C12 myoblasts with mtRed plasmid (Nakamura
et al., 2006) and examined mitochondrial distribution upon ex-
posure to Dex or hMstn or under serum starvation conditions.
Control C2C12 myoblasts demonstrated elongated and tubular
mitochondrial morphology, features characteristic of healthy
mitochondria (Figure 1A). However, mitochondria appeared
punctate and fragmented upon treatment with Dex or hMstn
and during serum starvation (Figure 1A).
In addition to disrupting mitochondrial organization, Dex and
hMstn also impaired mitochondrial activity, as assessed through
MitoTracker Red staining (see Figure S1A online). Moreover, we
noted decreased MitoTracker Red accumulation in C2C12
myoblasts andmyotubes treatedwithDex or hMstn (Figure S1B).
Expectedly, C2C12myoblasts andmyotubes treatedwith Dex or
hMstn or during serum starvation underwent marked depolariza-
tion after Oligomycin (Olm) treatment as compared to control
C2C12 myoblasts and myotubes (Figure 1B and Figure S1C).
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) causes
rapid mitochondrial membrane depolarization. Consistent with
this, a sharp decrease in mitochondrial potential was observed
in all the samples immediately after the addition of CCCP (Fig-
ure 1B and Figure S1C). In addition, Dex, hMstn, and serum
starvation also resulted in reduced mtDNA copy number per
nuclear DNA (nuDNA) (mtDNA:nuDNA) ratio in C2C12 myotubes
(Figure 1C).
Dex, hMstn, and Serum Starvation Enhanced Mul1
Expression
We next examined the expression of known regulators of mito-
chondrial dynamics in C2C12 myotubes exposed to Dex or
hMstn, and during serum starvation conditions. Fis1 and Drp1,
which promote the fragmentation of mitochondria (Romanello
et al., 2010), were upregulated in serum-starved, Dex- and
hMstn-treated C2C12 myotubes (Figure 1D). While we observed
no change in the mRNA expression of Mfn2 (Figure 1D),
a GTPase that coordinatesmitochondrial fusion, we found signif-
icantly reduced Mfn2 protein levels in human primary myotubes
(hMb15) and in C2C12 myotubes subjected to serum starvation
RE
TR
A614 Cell Metabolism 16, 613–624, November 7, 2012 ª2012 Elsevieror treatment with Dex or hMstn when compared to control (Fig-
ure 1E and Figure S1D). A similar decrease in Mfn2 protein level
was observed in C2C12myotubes and H9c2 rat cardiomyocytes
treated with Mstn expressing CHO cell-conditioned media (CHO
Mstn) (Figure 1F). We noted that Mfn1 gene expression, a
homolog of Mfn2 also involved in mitochondria fusion, was
elevated in C2C12 myotubes in response to treatment with
hMstn and during serum starvation (Figure 1D). However, Mfn1
protein levels were unchanged in serum-starved, Dex- and
hMstn-treated human primary myotubes (hMb15), although
a slight increase was observed in C2C12 myotubes (Figure 1E
and Figure S1D). A slight increase in Mfn1 protein levels was
also observed in CHO Mstn-treated C2C12 myotubes and
H9c2 cells (Figure 1F). In addition, Bnip3, a well-characterized
facilitator of mitochondrial disintegration and autophagy in
skeletal muscles, was upregulated by 8-, 6-, and 3-fold in
serum-starved, hMstn-treated, and Dex-treated C2C12 myo-
tubes, respectively, when compared to the control (Figure 1D).
Mul1 is a recently discovered mitochondrial E3 ligase impli-
cated in the fragmentation of mitochondria (Braschi et al.,
2009; Li et al., 2008; Zhang et al., 2008). We observed the upre-
gulation of Mul1 expression by 5-, 4-, and 2.5-fold in serum-
starved, hMstn-treated, and Dex-treated C2C12 myotubes,
respectively (Figure 1D). Additionally, a dose-dependent in-
crease in Mul1 expression was observed in C2C12 myotubes
and H9c2 cells exposed to increasing concentrations of hMstn
(Figures S1E and S1F). A similar increase in Mul1 protein level
was observed in serum-starved, Dex-treated, and hMstn-
treated human primary (hMb15) and C2C12myotubes (Figure 1E
and Figure S1D). Immunoblot analysis further confirmed
increasedMul1 protein levels in C2C12myotubes andH9c2 cells
challenged with CHO Mstn (Figure 1F). Along withMul1, we also
noted increased expression of additional mitochondrial E3
ligases, namely March5 and Park2, and the kinase Park6, upon
exposure to hMstn and during serum starvation (Figure 1D).
FoxO Transcription Factors Regulate Mul1 Expression
Analysis of the human and mouse Mul1 gene promoters (2 kb),
for putative skeletal muscle-wasting-associated transcription
factor binding motifs (Table S1) (Sandri et al., 2004), revealed
six putative FoxO transcription factor-binding sites in the human
Mul1 promoter (Figure 2A). Importantly, FoxO transcription
factors are involved in enhancing the ubiquitin-proteasome and
autophagy-lysosomal pathways during skeletal muscle wasting
(Mammucari et al., 2007; Romanello et al., 2010; Sandri et al.,
2004; Zhao et al., 2007). To determine if FoxO transcription
factors regulate Mul1 gene expression, a 2 kb Mul1-Luc
promoter-reporter construct and plasmids that express wild-
type FoxO1 (WT-FoxO1), constitutively active FoxO1 (ca-
FoxO1), wild-type FoxO3 (WT-FoxO3), or constitutively active
FoxO3 (ca-FoxO3) were cotransfected into C2C12 myoblasts
and then differentiated into myotubes. Increased Mul1 promoter
activity was observed in the presence of ca-FoxO1 and ca-
FoxO3 when compared to empty vector control (Figure 2A).
WT-FoxO1- and WT-FoxO3-dependant Mul1 promoter-reporter
activity was significantly elevated when compared to empty
vector control, but lower when compared to the Mul1
promoter-reporter activity detected upon transfection with
constitutively active FoxO1 or FoxO3, respectively (Figure 2A).
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Figure 1. Dexamethasone, Myostatin, and Serum Starvation Induced Mitochondrial Dysfunction and Promoted Mul1 Expression In Vitro
(A) Visualization of mitochondria in C2C12myoblasts following 24 hr treatment with Dexamethasone (Dex) and recombinant humanMyostatin protein (hMstn) and
during serum starvation. Mitochondria were visualized by mtRed fluorescence. Scale bars represent 10 mm.
(B) Quantitative analysis of the change in tetramethylrhodamine, methyl ester (TMRM) fluorescence in mitochondria from C2C12 myotubes. Cells were treated
with Dex and hMstn and subjected to serum starvation for 24 hr before TMRM loading. Arrows indicate when 5 mMof oligomycin (Olm) and 5 mMof protonophore
Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) were added. Statistical significance was assessed between control and treatment groups after Olm
treatment and before addition of CCCP. Values are means ± SD; n = 8. *p < 0.01.
(C) Quantitative analysis of the ratio of mtDNA copy number to nuDNA (mtDNA:nuDNA) following treatment with Dex and hMstn and during serum starvation in
C2C12 myotubes. Values are means ± SD; n = 5. *p < 0.01.
(D) RT-qPCR analysis of mitochondrial gene expression in C2C12 myotubes treated with Dex and hMstn and during serum starvation for 24 hr. Gene expression
was normalized to three endogenous controls, Gapdh, Actb, and Gusb, using the DDCT method. Values are means ± SD; n = 6. *p < 0.01.
(E) Immunoblot (IB) analysis of Mul1, Mfn1, and Mfn2 protein expression in human primary myotubes (hMb15) treated with Dex and hMstn and during serum
starvation.
(F) IB analysis of Mul1, Mfn1, and Mfn2 protein expression in H9c2 rat cardiomyocytes and C2C12 myotubes after 24 hr treatment with (+) or without ()
eukaryotically produced Mstn protein (CHO Mstn) (see also Figure S1).
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DEndogenous FoxO1 and FoxO3 expression in C2C12 myotubes
was also silenced by siRNA to delineate the specificity of the
FoxO transcription factors in regulating the expression of Mul1Cell Mduring serum starvation and treatment with Dex or hMstn
(Figure 2B and Figure S2B). Results demonstrated that the
knockdown of FoxO1 and FoxO3 led to a reduction in Mul1etabolism 16, 613–624, November 7, 2012 ª2012 Elsevier Inc. 615
Figure 2. FoxO Transcription Factors Regu-
late Mul1 Expression
(A) Schematic representation of the human Mul1
(hMul1) promoter-reporter construct used in sub-
sequent luciferase assays (Top). Consensus FoxO
binding sites (RTAAAYA), as determined by in silico
analysis, are represented by stars. (Bottom) Anal-
ysis of hMul1 promoter-reporter activity in 72 hr
differentiated C2C12myoblasts cotransfected with
hMul1 reporter and with WT-FoxO1, ca-FoxO1,
WT-FoxO3, or ca-FoxO3. All values are normalized
to renilla luciferase and are compared to empty
vector control (Control). Data representmean ± SD;
n = 8. *p < 0.01.
(B) Analysis of hMul1 promoter-reporter luciferase
activity in FoxO1 and FoxO3 knockdown C2C12
myoblasts differentiated for 72 hr and treated with
Dex or hMstn and in response to serum starva-
tion for 24 hr. All values are normalized to renilla
luciferase activity and are compared to empty
vector control (Control). Data representmean ± SD;
n = 8. *p < 0.01.
(C) RT-qPCR analysis of Mul1 expression in TA
muscle (left) and C2C12 myotubes (right) trans-
fected with ca-FoxO1, ca-FoxO3, or empty vector
control (Control). Gene expression was normalized
to the endogenous control,Gapdh, using theDDCT
method. Values are means ± SD; n = 6. *p < 0.01.
(D) IB analysis of Mul1, FoxO3, FoxO1, and Mfn2
protein levels in TA muscle transfected with
ca-FoxO1, ca-FoxO3, or empty vector control
(Control).
(E) Electrophoretic mobility shift assay (EMSA)
on nuclear extracts from 293T cells transiently
transfected with HA-ca-FoxO3 and a double-
stranded 32P-labeled oligonucleotide probe
containing hMul1 FoxO binding sites (1,220 bp
and 1,204 bp). A band shift was noted after the
addition of nuclear extract and a supershift upon
addition of anti-HA antibody, confirming interaction
of HA-ca-FoxO3 with the probe.
(F) To assess for interaction between FoxO3 and
Mul1, chromatin immunoprecipitation (ChIP) was
performed in C2C12 myotubes stably transfected
with HA-ca-FoxO3. Cultures were either grown
under control conditions () or subjected to 24 hr of
serum starvation (+).
(G) Analysis of mtDNA:nuDNA ratio in M. tibialis
anterior (TA) muscle (left) and C2C12 myotubes
(right) transfected with ca-FoxO1, ca-FoxO3, or
empty vector control (Control). Values are means ±
SD; n = 5. *p < 0.01 (see also Figure S2).
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EDpromoter-reporter-driven luciferase activity during serum
starvation and treatment with Dex or hMstn, when com-
pared to scrambled siRNA (Mock-siRNA) transfected controls
(Figure 2B).
Knockdown of FoxO1 and FoxO3 also resulted in the reduc-
tion of Mul1 protein levels and an increase in Mfn2 protein
expression (Figure S2B). Moreover, transfection of ca-FoxO1
or ca-FoxO3 into TA muscle led to increased Mul1 mRNA and
protein expression (Figures 2C and 2D). Similarly elevated
Mul1 mRNA and protein expression was observed in C2C12
myotubes expressing ca-FoxO1 or ca-FoxO3 (Figure 2C and
Figure S2A). Importantly, we found significantly reduced Mfn2
protein levels in both ca-FoxO1- and ca-FoxO3-transfected TA
R
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a significant reduction in mtDNA:nuDNA ratio was observed in
C2C12 myoblasts and myotubes and in TA muscle following
transfection of either ca-FoxO1 or ca-FoxO3 (Figure 2G and
Figure S2C). In agreement, knockdown of FoxO1 or FoxO3 by
siRNA significantly rescued the reduced mtDNA:nuDNA ratio
observed in C2C12myotubes during serum starvation and treat-
ment with Dex or hMstn (Figure S2D).
To validate interaction of FoxO transcription factors with
the Mul1 promoter, electrophoretic mobility shift assay (EMSA)
was performed, using a nuclear extract from HA tagged ca-
FoxO3-transfected 293T cells and a probe containing FoxO
binding sites from the Mul1 promoter. A strong band shift wasInc.
Figure 3. Starvation and Denervation
Promoted the Expression of Mul1 and
Reduced mtDNA:nuDNA Ratio In Vivo
(A) RT-qPCR analysis of mitochondrial gene
expression changes in M. gastrocnemius (GAS)
muscle isolated from starved and denervated
mice. Gene expression was normalized to three
endogenous controls, Gapdh, Actb, and Gusb,
using the DDCT method. Values are means ± SD;
n = 5. *p < 0.01.
(B) IB analysis of Mstn, FoxO3, p-FoxO3, Mul1,
and Mfn2 protein levels in GAS muscle isolated
from control and starved mice (top). IB analysis
of Mul1 and Mfn2 protein levels in M. extensor
digitorum longus (EDL) muscle isolated from
control and starved mice (bottom).
(C) Quantitative assessment of Mstn levels in
serum isolated from mice starved for 48 hr. Values
are means ± SD; n = 5. *p < 0.01.
(D) IB analysis of Mstn, FoxO3, p-FoxO3, Mul1,
and Mfn2 protein levels in GAS muscle isolated
from control and denervated mice.
(E) Analysis of mtDNA:nuDNA ratio in M. bicep
femoris (BF), EDL, GAS, M. quadriceps (QUAD),
soleus, and TA muscles isolated from control and
starved mice. Values are means ± SD; n = 5.
*p < 0.01.
(F) Analysis of mtDNA:nuDNA ratio in EDL, GAS,
soleus, and TA muscles isolated from control and
denervated mice. Values are means ± SD; n = 5.
*p < 0.01.
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EDobserved upon incubation of the g-ATP-[32P]-labeled probe with
the ca-FoxO3 expressing nuclear extract (Figure 2E). Addition-
ally, a supershift was observed upon addition of anti-HA
antibody, indicating that HA-ca-FoxO3 was bound to the Mul1
promoter (Figure 2E). Chromatin immunoprecipitation (ChIP)
verified that HA-ca-FoxO3 interacted with the Mul1 promoter
and that the binding of HA-ca-FoxO3 to the Mul1 promoter
increased further upon serum starvation in C2C12 myotubes
(Figure 2F).
Starvation and Denervation Enhanced Mul1 Levels and
Depleted mtDNA:nuDNA Ratio In Vivo
Similar to the in vitro skeletal-muscle-wasting models, elevated
Mul1 expression was detected in M. gastrocnemius (GAS)
muscles from both starved and denervated mice when com-
pared to controls (Figure 3A). Additionally, the mRNA expression
profile of other mitochondrial genes was also comparable to the
in vitro muscle-wasting models (compare Figure 1D with Fig-
ure 3A). Immunoblot analysis confirmed elevated Mul1 protein
levels in GAS and M. extensor digitorum longus (EDL) muscles
during starvation and in GAS muscle during denervation
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elevated Mstn and reduced phosphory-
lated FoxO3 (p-FoxO3) protein levels
were observed in muscle tissue isolated
from starved and denervated mouse
models when compared to respective
controls (Figures 3B and 3D). Circulatory
levels of Mstn were also elevated instarved mice (Figure 3C). During starvation and denervation,
we observed reduced Mfn2 protein levels in skeletal muscles
(Figures 3B and 3D). However, Mfn2 mRNA expression was
unchanged in GAS muscles collected from both starved and
denervated mice when compared to control (Figure 3A). Impor-
tantly, mtDNA:nuDNA ratio was also significantly reduced in
numerous skeletal muscle tissues isolated from starved and
denervated mice (Figures 3E and 3F).
Mul1 Ubiquitinated and Targeted Mfn2 for Degradation
To verify whether Mul1 directly facilitates the degradation of
Mfn2 through the ubiquitin-proteasome system, we induced
Mul1 expression in C2C12 myotubes by serum starvation and
examined the protein levels of Mfn2 in the presence or absence
of the proteasome inhibitor, MG132. Immunoblot analysis
demonstrated that serum starvation-induced loss of Mfn2
protein in C2C12 myotubes was prevented through MG132-
mediated blockade of the proteasome, despite sustained upre-
gulation of Mul1 (Figure 4A). Furthermore, proteasome inhibition
also prevented a reduction in mtDNA:nuDNA ratio in serum-
starved myotubes (Figure S3A).November 7, 2012 ª2012 Elsevier Inc. 617
Figure 4. Mul1 Ubiquitinated and Targeted
Mfn2 for Degradation through the Ubiquitin-
Proteasome Pathway
(A) IB analysis of Mul1 and Mfn2 protein levels in
control () and 24 hr serum-starved (+) myotube
cultures in the absence () or presence (+) of the
proteasome inhibitor MG132.
(B) Coimmunoprecipitation (Co-IP) analysis of
C2C12 myoblasts transfected with Flag-tagged
Mul1 (Flag-Mul1) and myc-tagged Mfn2 (myc-
Mfn2) constructs. Interaction between Mul1 and
Mfn2 was verified through the transfection of
a RING finger deletion Mul1 construct (Flag-
Mul1DR). IB analysis of the ubiquitinated proteins
coimmunoprecipitated with Flag-Mul1 (bottom).
(C) Mul1 ubiquitinated Mfn2 in vitro. Myc-DDK-
hMfn2 (Mfn2; full length) (1 mM)was incubated with
yeast UBE1 (E1) (125 nM), hUbcH5c (E2) (4 mM),
His6-biotin-hUB (Ub) (5 mM), and increasing
concentrations of GST-hMul1 (Mul1; full length)
(50, 150, and 250 nM) for 1 hr. IB analysis with an
anti-ubiquitin antibody (Ub) is shown, and the
ubiquitinated Mfn2 protein (Mfn2-Ub) is indicated
within the brackets.
(D) To confirm Mul1 ubiquitin ligase activity on
Mfn2, myc-DDK-hMfn2 (Mfn2; full length) (1 mM)
was incubated with yeast UBE1 (E1) (125 nM),
hUbcH5c (E2) (4 mM), His6-biotin-hUB (Ub) (5 mM),
and increasing concentrations of GST-hMul1
(Mul1; full length) (150 and 250 nM) for 1 hr. IB
analysis with anti-Mfn2 is displayed, and band
shifts indicate polyubiquitinated Mfn2.
(E) IB analysis with anti-Ub antibody on the
Mfn2-immunoprecipitated complex collected from
Mul1-silenced (Mul1-siRNA) and scrambled siRNA
(Mock-siRNA)-transfected serum-starved and
control C2C12 myotubes. Ubiquitinated Mfn2
protein (Mfn2-Ub) is indicated within the brackets.
IB analysis ofMul1 andMfn2 inputs are shown (see
also Figure S3).
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myoblasts were cotransfected with either Flag-Mul1 or a Flag-
Mul1 deletion construct, where the RING finger domain has
been deleted (Flag-Mul1DR), together with the myc-Mfn2
expression construct. Flag-Mul1 protein complex was immuno-
precipitated using anti-Flag antibodies and analyzed for coim-
munoprecipitation of myc-Mfn2. Immunoblot analysis revealed
that Mfn2 coimmunoprecipitated with Mul1, suggesting that
Mul1 associates with Mfn2 (Figure 4B). Coimmunoprecipitation
experiments also identified that the RING finger domain of
Mul1 is required for this interaction, as Mul1 did not coimmuno-
precipitate with Mfn2 in myoblasts cotransfected with Flag-
Mul1DR and myc-Mfn2 (Figure 4B).
An immunoblot with anti-ubiquitin antibody on the Flag-Mul1
coimmunoprecipitated complex further demonstrated the pres-
ence of several ubiquitinated proteins, indicating the ubiquitin
ligase activity conferred by Mul1 (Figure 4B). To determine
whether Mul1 directly ubiquitinated Mfn2, we performed an
in vitro ubiquitination assay. Incubation with increasing concen-
tration of Mul1 resulted in increased levels of ubiquitinated Mfn2
(Figures 4C and 4D). Ubiquitinated Mfn2 bands were detected
above the molecular weight of nonubiquitinated Mfn2 (Figures
4C and 4D). To confirm whether Mul1 ubiquitinated Mfn2 in
RE
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silenced by siRNA, and protein lysates were immunoprecipated
with anti-Mfn2 antibodies. Subsequent anti-Ub immunoblot
analysis of the Mfn2 immunoprecipitated lysates revealed
reduced amounts of ubiquitinated Mfn2 in Mul1-silenced
C2C12myotubes, when compared to scrambled siRNA controls
(Mock-siRNA) (Figure 4E).
In addition to ubiquitinated Mfn2, we also detected ubiquiti-
nated Mul1 (Figure 4C). We suggest that Mul1 ubiquitination was
due to Mul1 autoubiquitination, since incubation of increasing
concentrations of Mul1 with E1, E2, and Ub correlated in a
dose-dependent manner with increased levels of ubiquitinated
Mul1 (Figure S3B).
Mul1 Overexpression Facilitated Mitochondrial
Dysfunction and Skeletal Muscle Atrophy
To further characterize Mul1 function, we cotransfected
C2C12 myoblasts with Mul1 overexpression vector (GFP-Mul1)
and mtRed and examined mitochondria morphology. Con-
focal imaging revealed that overexpression of Mul1 promoted
mitochondrial fragmentation in C2C12 myoblasts (Figure 5A).
Furthermore, transfection of GFP-Mul1 into C2C12 myoblasts
resulted in significantly increased mitochondrial depolarizationInc.
Figure 5. Mul1 Facilitated Mitochondrial
Dysfunction
(A) Visualization of mitochondria following over-
expression of a GFP-tagged Mul1 construct (GFP-
Mul1) and empty GFP vector (GFP) in C2C12
myoblasts. Mitochondria were visualized by
mtRed fluorescence. Scale bars represent 10 mm.
(B) Quantitative analysis of TMRM fluorescence
changes over mitochondrial regions in C2C12
myoblasts transfected with either control (GFP) or
GFP-Mul1. Arrows indicate when 5 mM of Olm and
5 mM CCCP were added. Statistical significance
was assessed between GFP- and GFP-Mul1-
transfected C2C12 myotubes after Olm treatment
and before addition of CCCP. Values are means ±
SD; n = 8. *p < 0.01.
(C) Analysis of mtDNA:nuDNA ratio in C2C12
myoblasts (left), myotubes (middle), and TA
muscle (right) with either empty GFP vector (GFP)
or GFP-Mul1 (right). Values are means ± SD; n = 5.
*p < 0.01. IB analysis of Mul1 and Mfn2 in
myoblasts, myotubes, and TA muscles is also
displayed.
(D) Representative microscopy images of TA
muscle sections 9 days after GFP and GFP-Mul1
overexpression vector transfection (top). Scale
bars represent 100 mm. Laminin staining on GFP-
and GFP-Mul1-transfected TA muscle (bottom).
Scale bars represent 50 mm. Muscles were
collected 9 days posttransfection. The contralat-
eral limb TA muscle was transfected with the
control GFP vector.
(E) Frequency distribution (%) of myofiber area
(mm2) in TA muscle cryosections 9 days post-
transfection with either GFP or GFP-Mul1 over-
expression vector. The contralateral limb TA
muscle was transfected with the control GFP
vector. Four hundred myofibers from three sec-
tions per group were analyzed using the ImagePro
Plus software.
(F) Quantitative analysis of TMRM fluorescence
changes in mitochondria from C2C12 myoblasts
transfected with either control nonsilencing shRNA
(shCon) or Mul1 shRNA (shMul1). Arrows indicate
when 5 mM of Olm and 5 mM CCCP were added.
Statistical significance was assessed between
shCon- and shMul1-transfected C2C12 myotubes
after Olm treatment and before addition of CCCP.
Values are means ± SD; n = 8. *p < 0.01.
(G) Analysis of mtDNA:nuDNA ratio in TA muscle
isolated from control or 48 hr starved mice 9 days
after transfection with either shCon or shMul1.
Values are means ± SD; n = 5. *p < 0.01.
(H) Frequency distribution (%) of myofiber area (mm2) in TA muscle cryosections 9 days posttransfection with either shCon or shMul1 and following an additional
period of 48 hr starvation. The contralateral limb TA muscle was transfected with shCon. Four hundred myofibers from three sections per group were analyzed
using the ImagePro Plus software. (See also Figure S4.)
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TEwhen compared to the GFP empty vector-transfected control
after Olm treatment (Figure 5B). Ectopic expression of Mul1 in
C2C12 myoblasts and myotubes and in TA muscle also resulted
in significantly reducedmtDNA:nuDNA ratio (Figure 5C). Further-
more, overexpression of Mul1 in TA muscle led to reduced
myofiber area and muscle weight when compared to controls
(Figures 5D and 5E and Figure S4A).
When Mul1-specific siRNA (Mul1-siRNA) was transfected
into C2C12 myoblasts, we observed an expansive and elon-Cell Mgated mitochondrial network (visualized by mtRed), which
was qualitatively greater than the mitochondrial network in
the scrambled siRNA (Mock-siRNA)-transfected control (Fig-
ure S4B). Knockdown of Mul1 in C2C12 myoblasts also ap-
peared to confer resistance to mitochondrial fragmentation
induced by Dex and hMstn and in response to serum starvation
(Figure S4B) and prevented mitochondrial depolarization even
after treatment with Olm (Figure 5F). We also observed a
stark increase in mtDNA:nuDNA ratio in shMul1-transfectedetabolism 16, 613–624, November 7, 2012 ª2012 Elsevier Inc. 619
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Mul1-Induced Mitophagy during Muscle WastingTA muscle when compared to the control shRNA (shCon)
transfected contralateral TA muscle (Figure 5G). Moreover,
we observed a rescue of mtDNA:nuDNA ratio in the shMul1-
transfected TA muscle of starved mice undergoing muscle
wasting, when compared to shCon-transfected starved mice,
back to levels comparable to shCon-transfected control mice
(Figure 5G). Additionally, Mul1 silencing in C2C12 myotubes
blocked the reduction in mtDNA:nuDNA ratio observed follow-
ing treatment with Dex or hMstn or during serum starvation,
enhanced the protein levels of Mfn2, and further prevented
hMstn-mediated degradation of Mfn2 (Figures S4C and S4D).
In support, knockdown of Mul1 in TA muscle partially rescued
the reduced myofiber area and muscle weight observed during
starvation when compared to control (shCon)-transfected TA
muscles (Figure 5H, Figures S4E and S4F). Furthermore,
elevated amounts of Mfn2 protein were observed in both
shMul1-transfected TA muscles of starved and control mice
when compared to respective shCon-transfected contralateral
TA muscles (Figure S4G).
Mul1 Overexpression Induced Mitophagy
Significant reduction in mitochondrial copy number is asso-
ciated with mitophagy, the selective degradation of mitochon-
dria through the autophagy-lysosomal pathway (Youle and
Narendra, 2011). Consistent with enhanced mitophagy, we
noted increased autophagosome formation and enhanced levels
of LC3-II in C2C12 cultures exposed to Dex and hMstn and in
response to serum starvation (Figures S5A and S5B). Hence,
we surmised that Mul1 overexpression stimulated by Dex and
hMstn and in response to serum starvation might serve as
a potent signal for mitophagy. Indeed, when C2C12 myoblasts
were treated with Dex or hMstn or grown under serum starvation
conditions, we noted colocalization of mitochondria, demar-
cated by mtRed, with GFP-LC3-positive autophagosomes,
which is indicative of mitophagy (Figure S5C). To further quantify
mitophagy in muscle cultures, we ectopically expressed a lyso-
somal protease-resistant coral protein, pMT-mKeima-Red,
which localizes to the matrix of the mitochondria (Kogure et al.,
2006), in C2C12myotubes prior to serum starvation or treatment
with Dex or hMstn. PMT-mKeima-Red exhibits a bimodal ex-
citation maximum at 440 and 586 nm that occurs when the mito-
chondria-targeted protein is found in a neutral or acidic pH,
respectively. By quantifying the 586/440 nm excitation ratio,
the population of pMT-mKeima-Red-tagged mitochondria fused
to lysosomes can be ascertained. Serum-starved, Dex- and
hMstn-treated pMT-mKeima-Red-expressing C2C12 myotubes
demonstrated a high 585/440 nm ratio when compared to
control, confirming that a large population of mitochondria in
the C2C12 myotubes were fused to lysosomes in response to
catabolic stimuli (Figure 6A). Furthermore, pMT-mKeima-Red-
expressing myotubes treated with Olm and CCCP, two potent
inducers of mitophagy, demonstrated the greatest degree of
mitophagy as the 586/440 nm ratio was the highest across all
the treatments (Figure 6A).
GFP-Mul1 tagged mitochondria colocalized with RFP-LC3-
positive autophagosomes in C2C12 myoblasts 24 hr after
transfection of GFP-Mul1 overexpression plasmid (Figure 6B).
To confirm whether Mul1 overexpression promoted mitophagy,
we ectopically expressed pMT-mKeima-Red in GFP-Mul1-
RE
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ratio. GFP-Mul1-expressing myotubes exhibited a higher 585/
440 nm ratio compared to the GFP control C2C12 myotubes,
further supporting Mul1 as an inducer of mitophagy (Figure 6C).
GFP-Mul1 overexpression in C2C12 myotubes and in TA
muscle also resulted in increased levels of LC3-II (Figure 6D).
However, knockdown of Mul1 impeded the increased LC3-II
levels observed in C2C12 myotubes treated with Dex and
hMstn and during serum starvation (Figure S5D). A similar
reduction in LC3-II levels was also observed upon knockdown
of Mul1 in TA muscle of starved mice (Figure 6E). Consistent
with the above results, Mfn2 protein levels were markedly
reduced in both C2C12 myotubes and TA muscles overex-
pressing GFP-Mul1 (Figure 6D). Conversely, knockdown of
Mul1 in C2C12 myotubes and TA muscle increased Mfn2
protein levels despite continued presence of Dex, hMstn, or
starvation stimuli, when compared to respective controls (Fig-
ure S5D and Figure 6E). Furthermore, knockdown of Mul1 in
serum-starved, Dex- or hMstn-treated pMT-mKeima-Red-
transfected C2C12 myotubes led to a low 585/440 nm ratio
when compared to respective scrambled siRNA-transfected
controls, further confirming that Mul1 knockdown prevented
mitophagy in myotube cultures exposed to catabolic stimuli
(Figure 6F).
Mul1 Was Weakly Expressed in Slow-Twitch Muscles
and in Differentiated Myotubes
Although we have demonstrated that increased expression
of Mul1 imparts pathological consequences during skeletal
muscle wasting, the normal physiological role of Mul1 in skeletal
muscle remains unclear. Hence, we next quantified the expres-
sion of Mul1 in fast- and slow-twitch muscles. Interestingly, the
predominantly slow-twitch (type I) soleus muscle displayed
reduced amounts of Mul1 together with lower levels of Mstn,
when compared to the predominantly fast-twitch (type IIa/b/x)
TA muscle (Figure 7A). Consistent with this, Mfn2 protein level
and mtDNA:nuDNA ratio was higher in soleus muscle when
compared to TA muscle (Figure 7B).
We further noted temporal variation in Mul1 expression
during myogenesis (Figure 7C). Specifically, Mul1 protein levels
were less in differentiated C2C12 myotubes when compared
to proliferating C2C12 myoblasts (Figure 7C). In addition, re-
duced Mul1 levels in myotubes were associated with
decreased Mstn protein and a reciprocal increase in Mfn2
abundance (Figure 7C). In agreement, the mtDNA:nuDNA ratio
was also increased in myotubes when compared to myoblasts
(Figure 7D).
DISCUSSION
Mitochondrial dysfunction underlies various human pathologies,
including adult-onset neurodegeneration, cancer, aging, cardio-
vascular disease, and metabolic disorders, such as obesity and
type 2 diabetes (Dodson et al., 2011; Emery, 2002; Evans, 2010;
Lecker, 2003). Autophagy-lysosome-mediated removal of
malfunctioning mitochondria in the skeletal muscles of fasted
and denervated mice was recently documented to result in
exacerbated skeletal muscle wasting (Romanello et al.,
2010). However, to date, the exact mechanism that results in
CT
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Figure 6. Mul1 Overexpression Induced Mitophagy
(A) Excitation ratio (586/440 nm) of pMT-mKeima-Red expressing C2C12myoblasts following serum starvation, Dex treatment, or hMstn treatment, where a high
586/440 nm ratio is indicative of increased mitophagy. Positive controls for the induction of mitophagy (Olm and CCCP) are also shown. Values are means ± SD;
n = 32. *p < 0.01.
(B) Visualization of GFP-Mul1 and RFP-LC3-positive autophagosomes in GFP-Mul1 and RFP-LC3 cotransfected C2C12 myoblasts. C2C12 myoblasts trans-
fected with the GFP empty vector (GFP) and RFP-LC3 are displayed. Scale bars represent 10 mm.
(C) Excitation ratio (586/440 nm) of pMT-mKeima-Red-expressing C2C12myoblasts cotransfected with either control (GFP) or GFP-Mul1 constructs. A high 586/
440 nm ratio is indicative of mitophagy. Values are means ± SD; n = 32. *p < 0.01.
(D) IB analysis of unlipidated (LC3-I) and lipidated (LC3-II) LC3, Mul1, and Mfn2 protein levels in C2C12 myotubes (left) or TA muscle (right) transfected with either
control (GFP) or GFP-Mul1 overexpression constructs.
(E) IB analysis of unlipidated (LC3-I) and lipidated (LC3-II) LC3, Mul1, and Mfn2 protein levels in TA muscle from control or 48 hr starved mice 9 days after
transfection with either shCon or shMul1. The contralateral limb TA muscle was transfected with shCon.
(F) Excitation ratio (586/440 nm) of pMT-mKeima-Red in serum-starved, Dex- or hMstn treated C2C12 myotubes expressing either scrambled control siRNA
(Mock-siRNA) or Mul1-siRNA (Mul1-siRNA-1 andMul-siRNA-2). A high 586/440 nm ratio is indicative of mitophagy. Values are means ± SD; n = 32. *p < 0.01 (see
also Figure S5).
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Dmitochondria malfunction is not well defined. Here we show that
various muscle wasting signals, such as Dex, Mstn, starvation,
and denervation, not only disrupt mitochondrial function butCell Malso promote mitophagy, the loss of mitochondria through the
autophagy-lysosomal system, via upregulation of the mitochon-
drial E3 ligase Mul1 (Figure S6).etabolism 16, 613–624, November 7, 2012 ª2012 Elsevier Inc. 621
Figure 7. Mul1 Was Weakly Expressed in
Slow-Twitch Muscles and in Myotube
Cultures
(A) IB analysis of Mstn, FoxO1, p-FoxO1, FoxO3,
p-FoxO3, Mul1, and Mfn2 protein levels in soleus
and TA muscles isolated from wild-type mice (left).
(Right) Densitometric analysis of IB showing
relative protein levels for Mstn, p-FoxO1/FoxO1,
p-FoxO3/FoxO3, Mul1, and Mfn2 normalized to
Tubulin. Values are means ± SD; n = 4. *p < 0.01.
(B) Analysis of mtDNA:nuDNA ratio in soleus and
TA muscles isolated from wild-type mice. Values
are means ± SD; n = 5. *p < 0.01.
(C) IB analysis of Mstn, FoxO1, p-FoxO1, FoxO3,
p-FoxO3, Mul1, and Mfn2 protein levels in both
proliferating C2C12 myoblasts and 96 hr differ-
entiated C2C12 myotube cultures (left). (Right)
Densitometric analysis of IB showing relative
protein levels forMstn, p-FoxO1/FoxO1, p-FoxO3/
FoxO3, Mul1, and Mfn2 normalized to Tubulin.
Values are means ± SD; n = 4. *p < 0.01.
(D) Analysis of mtDNA:nuDNA ratio in proliferating
C2C12 myoblasts and in 96 hr differentiated
C2C12 myotubes. Values are means ± SD; n = 4.
*p < 0.01.
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CT
EDThe mitochondrial E3 ligase, Mul1, is an outer mitochondrial
membrane protein that possesses two transmembrane domains
and a C-terminal RING finger domain and functions to regulate
the fusion and fission of mitochondria (Braschi et al., 2009; Li
et al., 2008; Zhang et al., 2008). Since we observed dramatic
upregulation of Mul1 in both muscle cell cultures and skeletal
muscle exposed to muscle-wasting stimuli, we surmised that
this mitochondrial E3 ligase might be responsible for mitochon-
drial dysfunction and loss associated with muscle wasting.
Indeed, ectopic overexpression of Mul1 promoted fragmen-
tation, depolarization, and removal of mitochondria through
mitophagy. Furthermore, knockdown of Mul1 expression in
C2C12 myoblasts led to an expansive and fused network of
healthy mitochondria and further prevented mitochondrial frag-
mentation, depolarization, and mitophagy induced in response
to muscle-wasting signals, suggesting that Mul1 is required for
the mitochondrial fission observed in wasting skeletal muscle
tissue. In addition, blockade of Mul1 partially rescued myofiber
atrophy in the presence of muscle-wasting stimuli, which indi-
cates that Mul1-induced mitochondrial dysfunction has a critical
role in the progression of skeletal muscle wasting.
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due to stabilization of mitochondrial fis-
sion proteins, degradation of mitochon-
drial fusion proteins, or a combination of
both (Chen et al., 2010; Romanello et al.,
2010). According to previously published
reports, Mul1 has been shown to stabilize
Drp1, a mitochondrial fission protein, re-
sulting in mitochondrial fragmentation
(Braschi et al., 2009). In this study, we
report that Mfn2 is a downstream target
of Mul1. Using coIP we clearly show that
Mfn2 physically interacts with Mul1 andthat the RING finger domain of Mul1 is essential for this inter-
action. Our results also confirm that Mul1 ubiquitinates and
targets Mfn2 for degradation through the ubiquitin-proteasome
pathway. Mfn2 is a critical mitochondrial fusion protein; thus
we hypothesize that Mul1-mediated removal of Mfn2 through
the ubiquitin-proteasome pathway, together with the stabiliza-
tion of Drp1, could account for the extensive mitochondrial
fission observed during skeletal muscle wasting.
FoxO3 is emerging as amaster regulator of the skeletal muscle
atrophy program. Indeed, FoxO3 activation in response to pro-
cachectic stimuli, such as Myostatin or Dexamethasone, results
in increased Atrogin-1 and MuRF1 and enhanced activation
of the ubiquitin-proteasome system (Lokireddy et al., 2011a;
McFarlane et al., 2006; Sandri et al., 2004; Zhao et al., 2007).
Furthermore, FoxO3 has also been shown to activate numerous
genes involved in the autophagy-lysosome pathway, particu-
larly LC3, Beclin-1, Atg7, Bnip3, Cathepsin L, and Gabarap1
(Mammucari et al., 2007; Romanello et al., 2010; Zhao et al.,
2007). In this study we have demonstrated that FoxO3 transcrip-
tionally regulates Mul1 expression during skeletal muscle wast-
ing. Several lines of evidence presented in this study confirm
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Athat Mul1 is transcriptionally regulated by FoxO transcription
factors. Initial in silico analysis identified six FoxO binding sites
in the 2 kb upstream promoter region of theMul1 gene. Further-
more, cotransfection of the Mul1 promoter-reporter construct
with constitutively active FoxO1/3 resulted in several-fold induc-
tion of Mul1 reporter activity. In addition, both EMSA and ChIP
assays confirmed that FoxO3 physically interacts with FoxO
binding elements in the Mul1 promoter region, which was
enhanced in the presence of muscle-wasting stimuli. Therefore,
we propose that enhanced FoxO1/3 activity during muscle
wasting results in increased transcription of Mul1, which in turn
ubiquitinates and degrades Mfn2, resulting in mitochondrial
dysfunction and loss during muscle wasting.
While the majority of this report has focused on understanding
the function of Mul1 during skeletal muscle wasting, we were
intrigued to observe differential expression of Mul1 between
fast- and slow-twitch muscles. Slow-twitch muscle, which is
aerobic in nature, had low amounts of Mstn and Mul1 together
with increased Mfn2 protein levels and mitochondrial number,
whereas in contrast, fast-twitch muscle, which is typically
anaerobic, expressed higher levels of Mstn and Mul1, reduced
Mfn2, and contained relatively low numbers of mitochondria.
Based on these data, we propose that Mul1, through regulating
mitochondrial number, plays an integral role in modulating the
energy balance of skeletal muscle and thus the aerobic/
anaerobic status of muscle fibers.
In conclusion, induction of muscle wasting led to enhanced
FoxO-mediated activation ofMul1, which further promotedmito-
chondrial fragmentation, depolarization, and mitophagy in both
muscle cell cultures and skeletal muscle tissue. Taken together,
these data presented in this manuscript underscore the impor-
tance of mitochondrial function in the progression of skeletal
muscle wasting.EXPERIMENTAL PROCEDURES
Animal Care and Handling
All wild-type mice (C57BL/6) used were obtained from National University of
Singapore Centre for Animal Resources (NUS CARE), Singapore. All experi-
ments were performed on 8- to 10-week-old mice according to approved
Singapore institutional animal ethics committee (IACUC) protocols. For all
animal experiments, mice had ad libitum access to water. For starvation
experiments, mice were deprived of food for 48 hr. In the case of denervation
experiments, the sciatic nerve was incised and mice were maintained for
a further 9 days postdenervation. Following the 9 day period, the mice were
sacrificed by CO2 asphyxiation, and various skeletal muscle tissues were
collected for relevant experiments.
Cell Culture and Treatments
The primary human myoblasts (hMb15) used in this study were kindly gifted by
Drs. Vincent Mouly and Gillian Butler-Browne (Institut de Myologie, France).
hMb15 cells were cultured and differentiated to myotubes as previously
described (Lokireddy et al., 2011b; McFarlane et al., 2011). H9c2 rat
cardiomyocytes, gifted by Dr Siu Kwan Sze, Nanyang Technological
University, Singapore, and 293T cells (ATCC, USA) were grown in DMEM
media containing 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin. Murine C2C12 myoblasts (ATCC, USA) were handled as
described previously (Lokireddy et al., 2011a). For treatment experiments,
C2C12 myoblasts and myotubes were exposed to either control (dialysis
buffer) or 25 mMof Dexamethasone (Dex) (dissolved in DMEM) (Sigma-Aldrich,
USA), bacterially or CHO cell expressed Myostatin (CHO-Mstn), or serum-free
DMEM (serum starvation) for 1 day. hMstn was expressed and purified from
RE
TRCell ME. coli according to a previously published protocol (McFarlane et al., 2011).
Myostatin-expressing CHO cells (CHO-Mstn) were kindly gifted by Se-Jin
Lee, Johns Hopkins University, USA. CHO-Mstn cells were propagated, and
conditioned media was collected as described previously (Zimmers et al.,
2002). CHO-Mstn cell conditioned media was used at a dilution of 1:5 in
appropriate media. To block proteasome activity, 10 mM of MG132 (Sigma-
Aldrich, USA) was added 12 hr prior to harvesting the cells.
Mitochondrial Membrane Potential Analysis
Mitochondrial membrane potential was measured by epifluorescence
microscopy based on the accumulation of tetramethylrhodamine, methyl ester
(TMRM) fluorescence in C2C12 myoblasts or myotubes, as per previously
described protocols (Gomes et al., 2011; Irwin et al., 2003; Romanello et al.,
2010), with slight modifications described in the Supplemental Experimental
Procedures.
Mitochondrial DNA Copy Number per Nuclear DNA Ratio
Quantification by qPCR
Relative copy number of mtDNA per nuDNA ratio was measured using
a protocol described previously (Chen et al., 2010). See the Supplemental
Experimental Procedures for details of primers and procedure used.
Quantification of Mitophagy
Quantification of mitophagy was performed according to a previously
published protocol (Katayama et al., 2011; Kogure et al., 2006). See the
Supplemental Experimental Procedures for detailed procedure.
Statistical Analysis
Statistical analysis was performed using Student’s t test, one-way ANOVA,
and two-way ANOVA. All values are expressed as means ± SD. The signifi-
cance was assessed and represented as *p < 0.01.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.cmet.2012.10.005.
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